Characterization and Quantification of Microplastics and Nanoplastics (MNPs) in Human Blood
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Centers for Disease Control and Prevention (CDC) plans to award a sole source firm fixed price contract to Columbia University to conduct laboratory analyses and collaborative research focused on the characterization and quantification of microplastics and nanoplastics (MNPs) in human blood. The contract will support efforts to validate extraction and measurement protocols and evaluate variability in MNP detection using advanced analytical instruments. This collaboration aims to combine the CDC's laboratory expertise with Columbia University's specialized analytical capabilities to develop reliable measurement methods and enhance scientific understanding of MNP presence in biological matrices. The performance period for this contract is expected to run from September 15, 2026, through September 14, 2028. The contract will be awarded under a sole source procurement authority, whereby the government intends to solicit and negotiate exclusively with Columbia University, although interested parties may express their capability to perform the work or submit proposals prior to the specified deadline. Responses must be submitted by June 19, 2026, and will be considered only to decide whether a competitive procurement is warranted; however, the government retains full discretion over whether to pursue competition. The project falls under NAICS code 541380 and will be conducted primarily in Atlanta, Georgia, with the CDC’s Office of Acquisition Services serving as the contracting office.
General Info
Agency
NAICS
Place of Performance
Atlanta, GA, 30341, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price contract to Columbia University to perform laboratory analyses and collaborative research activities to characterize MNPs, validate extraction and measurement protocols, and assess variability in MNP detection using advanced analytical instrumentation. The work will integrate CDC laboratory expertise with specialized analytical capabilities provided by the contractor to establish reliable measurement approaches and improve the scientific understanding of MNP detection in biological matrices. The anticipated period of performance is 09/15/2026 through 09/14/2028.
This contract action is for services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 12.102 and 41 U.S.C. § 1901 and 1903 (an interested persons may identify their interest and capability to respond to the requirement or submit proposals).
This notice of intent is not a request for competitive quotations; however, all quotations/responses received prior to the date and time below will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to Contract Specialist at zwh7@cdc.gov by 3:00PM (ET) on 06/19/2026.